Candel Therapeutics, Inc. (CADL) Tops Q1 EPS by 50c

Candel Therapeutics, Inc. (NASDAQ: CADL) reported Q1 EPS of $0.13, $0.50 better than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Candel Therapeutics, Inc. (CADL) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Ishares Msci South Korea Capped Etf (EWY) spreader of 10K contracts January 170 and 190 puts into Korean market lower
• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results